NCT06013033

DDX17 Orchestrate Septic Vascular Endothelial Pyroptosis by Controlling Gasdermin D Pore Formation

Zhongda Hospital·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Sepsis,Septic Shock
Study type
Observational
Sponsor & location
Primary sponsor
Zhongda Hospital
Timeline & enrollment
Phase
N/A
Start date
Sep 01, 2023
End date
Dec 31, 2025
Enrollment
60 participants
Primary outcome

28-day mortality

Summary

Objective: To investigate the correlation between plasma levels of DDX17 and GSDMD with
 vascular endothelial dysfunction and prognosis of in sepsis patients.
 
 Design: A single center, prospective, observational research. Participants: Patients with
 sepsis who are hospitalized to Southeast University Affiliated Zhongda Hospital and meet the
 diagnostic criteria for sepsis 3.0.
 
 Inclusion criteria:1. There is a potential or clear infection; 2. Sequential organ failure
 score (SOFA score) increases by more than or equal to 2 points compared to the baseline
 value; 3. Sign informed consent form.
 
 Exclusion criteria: Age18 years old or80 years old, pregnant women, tumor patients,
 including diseases that may be complicated with vascular endothelial damage: hypertension,
 acute and chronic hepatitis (hepatitis caused by virus), liver cirrhosis, PT prolongation
 after liver transplantation, acute myocardial infarction, chronic tubular nephritis, chronic
 renal insufficiency/maintenance hemodialysis, renal transplantation, interstitial pneumonia,
 acute pancreatitis, active phase of systemic lupus erythematosus Ulcerative colitis, Crohn's
 disease, HELLP syndrome.
 
 Primary outcome: 28-day mortality. Secondary outcome: Plasma levels of DDX17 and GSDMD, and
 their correlation with vascular endothelial injury, severity, and prognosis in sepsis
 patients.

ICD-10 classifications
Septic shockOther sepsisOther specified sepsisSepsis, unspecifiedSepsis due to other specified staphylococcus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06013033
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06013033 through Pure Global AI's free database. This phase not specified trial is sponsored by Zhongda Hospital and is currently Not yet recruiting. The study focuses on Sepsis,Septic Shock. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.